| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |